Home Top Movers Why BioCryst Pharmaceuticals, Inc. (BCRX) stock is climbing today?

Why BioCryst Pharmaceuticals, Inc. (BCRX) stock is climbing today?

BioCryst Pharmaceuticals, Inc. (BCRX) announced its first-quarter 2021 financial results after which the BCRX stock happened to be green as its per-share price went up by 8.05% to reach $11.54 a share as of this writing. BCRX stock was gloomy in the previous trading session and dropped by 3.00% at closing.Let’s analyze the financial results to justify the bullish sentiment.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

First Quarter Financial Results:

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

  • The total revenues of BCRX stock for the first three months ended March 31,2020, were $19.1 million which is significantly higher than the $4.8 million in the same tenure of the prior year.$10.9 million in ORLADEYO net revenue is the main reason for this increase.

    Read More
  • 3 Best Marijuana Stocks to Watch for in 2021
  • These are the Best Esport Stocks To Buy For 2021
  • Research and Development expenses for BioCryst stock increased to $42.4 million for Q1 2021 from $29.9 million in Q1 2020.Selling , general and administrative expenses of BCRX stock were increased to $22.1 million from  $15.9 million in the first three months of 2020.
  • BCRX stock reported $6.4 million interest and other income in the Q1 of 2020 and interest expense was $12.9 million for BCRX stock in the reported quarter.
  • BCRX stock suffered a net loss of $64.3 million or $0.36 per share in the first quarter of 2021 as compared to $37.6 million or $0.24 per share in the same period of the prior year.

Balance Sheet& Financial Outlook:

  • As of March 31, 2021, BioCryst Pharmaceuticals had cash, cash equivalents, restricted cash, and investments of $244.4 million as compared to $114.6 million at the same date of 2020.
  • BioCryst stock has not provided specific guidance regarding the revenue and operating expenses as ORLADEYO is in the launch phase.Management is optimistic that the current cash will be sufficient till 2023.

Key Developments:

  • The net revenue of ORLADEYO in the first quarter reached  $10.9 million.
  • BCRX stock got the approval for ORLADEYO in the United States, Japan, and Europe.
  • BioCryst stock reached an agreement with the U.S Food & Drug Administration(FDA) that the primary endpoint for the pivotal PNH trials of oral BCX9930 which are going to start in the second half of 2021 is the change from baseline in hemoglobin.

    Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Conclusion:

First-quarter 2021 financial results have made BCRX stock green in the pre-market today.The revenues, as well as the balance sheet of the BCRX stock, increased over the year which is a good sign for the BioCryst stock. Approvals from different marketplaces would prove to be fruitful for BCRX stock. Hence it can be a good bet for investors in the long run.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Tyme Technologies, Inc. (TYME) Stock Trends downwards Following Strong Q4 2021 Financials and Progress in OASIS Trial

Tyme Technologies, Inc. (TYME) stock prices was down by -6.92% shortly after market trading commenced on June 11th, 2021, bringing the price per share...

Prophase Labs Inc. (PRPH) stock surged during pre-market trading session. Let’s figure out why?

Prophase Labs Inc. (NASDAQ: PRPH) stock soared by 5.87% at last close as well as the PRPH stock price has been observed rising by...

Why Surgalign Holdings, Inc. (SRGA) stock is gloomy today?

Surgalign Holdings, Inc. (SRGA) stock announced the $50 million registered direct offering priced at the market under Nasdaq rules today on June 10, 2021,...

Exela Technologies Inc. (XELA) stock soars during pre-market. Here’s what you should know?

Exela Technologies Inc. (NASDAQ: XELA) stock gained by 8.28% at last close while the XELA stock price rises in the pre-market as well, by...

Atossa Therapeutics, Inc. (ATOS) stock gains during pre-market trading. Here’s to know why?

Atossa Therapeutics, Inc. (NASDAQ: ATOS) stock declined by 27.51% at the last close while the ATOS stock price rises further by 9.09% in the...

Magnachip Semiconductor Corporation (MX) stock is Popping High today: Why is it so?

Shares of the Magnachip Semiconductor Corporation (MX) stock were popping high after the announcement of its receival of unsolicited buyout bid from Cornucopia Investment...

Why is Autolus Therapeutics plc (AUTL) stock rising today?

Shares of  Autolus Therapeutics plc (AUTL) stock were rising today on June 11, 2021, following the release of the presentation data related to obe-cel...

Mustang Bio, Inc. (MBIO) stock is climbing today: Here is to know why.

Mustang Bio, Inc. (MBIO) stock announced the updated interim data from Phase 1/2 clinical trial of its MB-106 CD20-targeted, autologous CAR T today on...

Related News

Magnachip Semiconductor Corporation (MX) stock is Popping High today: Why is it so?

Shares of the Magnachip Semiconductor Corporation (MX) stock were popping high after the announcement of its receival of unsolicited buyout bid from Cornucopia Investment...

Mustang Bio, Inc. (MBIO) stock is climbing today: Here is to know why.

Mustang Bio, Inc. (MBIO) stock announced the updated interim data from Phase 1/2 clinical trial of its MB-106 CD20-targeted, autologous CAR T today on...

Here’s why Soligenix, Inc. (SNGX) stock is Popping High today

Soligenix, Inc. (SNGX) stock gained Pediatric Investigation Plan (PIP) waiver for HyBryte™ (SGX301 or hypericin) by European Medicines Agency (EMA) after which the SNGX...

Clover Health Investments Corp. (CLOV) stock rises during pre-market. Let’s find out why?

Clover Health Investments Corp. (NASDAQ: CLOV) stock declined by 23.61% at last close while the CLOV stock price gains by 5.73% in the pre-market...

GameStop Inc. (GME) stock plunged during after-hour session. Here’s the update

GameStop Inc. (NASDAQ: GME) stock gained by 0.85% at the last close while the GME stock price declines by 5.21% in the after-hours session....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam